Regenxbio Inc (RGNX)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -268,128 | -262,876 | 159,980 | -119,233 | -148,998 |
| Revenue | US$ in thousands | 85,585 | 89,470 | 446,639 | 291,249 | 59,562 |
| Operating profit margin | -313.29% | -293.81% | 35.82% | -40.94% | -250.16% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-268,128K ÷ $85,585K
= -313.29%
Regenxbio Inc's operating profit margin has exhibited significant fluctuations over the past five years, ranging from a low of -422.92% in 2019 to a high of 34.01% in 2021. The margin deteriorated notably in 2020 and continued to be negative in 2022 and 2023, indicating that the company's operating expenses exceeded its operating income during these periods. This suggests potential inefficiencies or challenges in cost management and revenue generation that have impacted the company's bottom line. Further analysis would be necessary to identify the specific factors contributing to these fluctuations and to assess the company's overall financial performance.
Peer comparison
Dec 31, 2023